Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9875411rdf:typepubmed:Citationlld:pubmed
pubmed-article:9875411lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9875411lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9875411lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:9875411lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:9875411lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:9875411lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:9875411lifeskim:mentionsumls-concept:C0121925lld:lifeskim
pubmed-article:9875411lifeskim:mentionsumls-concept:C0248122lld:lifeskim
pubmed-article:9875411pubmed:issue4lld:pubmed
pubmed-article:9875411pubmed:dateCreated1999-2-10lld:pubmed
pubmed-article:9875411pubmed:abstractTextBased on X-ray crystallographic analysis of MKC-442/human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) complex, analogues in which the N1-substituent is replaced with omega-functionalized alkyl groups were designed to improve the affinity for the enzyme. Synthesis of these compounds was carried out starting from MKC-442 by a sequence of reactions (N3-protection, removal of N1-ethoxymethyl group, alkylation, and N3-deprotection). The compounds were evaluated for anti-HIV activity. Structure-activity relationships are discussed in terms of the possible interaction with the enzyme.lld:pubmed
pubmed-article:9875411pubmed:languageenglld:pubmed
pubmed-article:9875411pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875411pubmed:citationSubsetIMlld:pubmed
pubmed-article:9875411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875411pubmed:statusMEDLINElld:pubmed
pubmed-article:9875411pubmed:monthJullld:pubmed
pubmed-article:9875411pubmed:issn0956-3202lld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:FujimotoKKlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:HayashiMMlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:TanakaHHlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:BabbLLlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:WalkerR TRTlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:MiyasakaTTlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:StammersD KDKlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:StuartD IDIlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:RecAAlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:JonesE YEYlld:pubmed
pubmed-article:9875411pubmed:authorpubmed-author:HopkinsA LALlld:pubmed
pubmed-article:9875411pubmed:issnTypePrintlld:pubmed
pubmed-article:9875411pubmed:volume9lld:pubmed
pubmed-article:9875411pubmed:ownerNLMlld:pubmed
pubmed-article:9875411pubmed:authorsCompleteYlld:pubmed
pubmed-article:9875411pubmed:pagination325-32lld:pubmed
pubmed-article:9875411pubmed:dateRevised2009-8-19lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:meshHeadingpubmed-meshheading:9875411-...lld:pubmed
pubmed-article:9875411pubmed:year1998lld:pubmed
pubmed-article:9875411pubmed:articleTitleAllosteric inhibitors against HIV-1 reverse transcriptase: design and synthesis of MKC-442 analogues having an omega-functionalized acyclic structure.lld:pubmed
pubmed-article:9875411pubmed:affiliationSchool of Pharmaceutical Sciences, Showa University, Tokyo, Japan.lld:pubmed
pubmed-article:9875411pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9875411pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed